You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Imatinib and/or Bosutinib Intolerance

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

Chronic Myeloid Leukemia Trial in Italy (Bosutinib)

Completed
  • Chronic Myeloid Leukemia
  • Alessandria, Italy
  • +44 more
Feb 2, 2023

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • (no location specified)
Dec 28, 2020

Type 2 Diabetes, PreDiabetes, Hypertension Trial in Worldwide (mHealth intervention, Standard care)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • mHealth intervention
  • Standard care
  • Tirana, Rruga E Dibrës, Albania
  • +3 more
Dec 5, 2022

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Dementia With Lewy Bodies Trial in Washington (Placebo Oral Tablet, Bosutinib Oral Tablet)

Completed
  • Dementia With Lewy Bodies
  • Placebo Oral Tablet
  • Bosutinib Oral Tablet
  • Washington, District of Columbia
    MedStar Georgetown University Hospital
Apr 4, 2022

Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

Not yet recruiting
  • Inherited Bone Marrow Failure Syndrome
  • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 20, 2023

Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

Completed
Has Results
  • Leukemia, Chronic Myelogenous
  • Toyoake-City, Aichi, Japan
  • +20 more
Apr 26, 2022

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Clinical Research of Drug Holiday Based on MRD Detection in GIST

Recruiting
  • Gastrointestinal Stromal Tumors
    • Beijing, Beijing, China
      Peking University People's Hospital
    May 11, 2023

    Maximum Tolerated Dose, GIST, Metastatic Adult Soft Tissue Sarcoma Trial in Spain (Selinexor, Imatinib)

    Recruiting
    • Maximum Tolerated Dose
    • +4 more
    • Sevilla, Andalucia, Spain
    • +5 more
    Oct 21, 2020

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Canada, United States (Dasatinib, Imatinib Mesylate, Laboratory

    Active, not recruiting
    Has Results
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Burbank, California
    • +340 more
    Jan 28, 2023

    Diabetes Type 2, Diabetes, Pre-diabetes Trial in Bothell (VIOME Precision Nutrition Program)

    Active, not recruiting
    • Diabetes Type 2
    • +2 more
    • VIOME Precision Nutrition Program
    • Bothell, Washington
      Viome Research Institute
    Jun 2, 2021

    Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)

    Completed
    • Gastrointestinal Stromal Tumors (GISTs)
    • Imatinib Mesylate
    • Seoul, Korea, Republic of
      Asan Medical Center
    Dec 30, 2022

    Gastrointestinal Stromal Tumor Trial in Philadelphia (Conventional Surgery, Imatinib Mesylate)

    Completed
    Has Results
    • Gastrointestinal Stromal Tumor
    • Conventional Surgery
    • Imatinib Mesylate
    • Philadelphia, Pennsylvania
      Radiation Therapy Oncology Group
    Oct 22, 2020

    Familial Mediterranean Fever, FMF Trial in Yerevan, Tbilisi, St.Petersburg (RPH-104)

    Recruiting
    • Familial Mediterranean Fever
    • FMF
    • RPH-104
    • Yerevan, Armenia
    • +4 more
    Jan 12, 2022

    Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)

    Not yet recruiting
    • Gastrointestinal Stromal Tumor of Rectum
    • Imatinib Mesylate
    • Local resection
    • Fuzhou, Fujian, China
      Weizhong Jiang
    Jul 23, 2023

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    Needs of 3L+ CP-CML and With T315I-mutated CML Patients

    Completed
    • Chronic Myeloid Leukemia
    • 3L Therapy
    • T315I
    • Lyon, France
      Novartis Investigative Site
    Nov 9, 2022

    Metastatic Gastrointestinal Stromal Tumor Trial in Worldwide (cabozantinib)

    Completed
    • Metastatic Gastrointestinal Stromal Tumor
    • Leuven, Belgium
    • +10 more
    Jul 14, 2021

    Myeloid Leukemia, Chronic Trial in Germany (dasatinib (SPRYCEL®))

    Active, not recruiting
    • Myeloid Leukemia, Chronic
    • dasatinib (SPRYCEL®)
    • Aachen, Germany
    • +52 more
    Jun 1, 2022

    Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

    Active, not recruiting
    • Gastrointestinal Stromal Tumor (GIST)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 28, 2022

    Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Imatinib Mesylate
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Dec 22, 2022